How to Buy Innoviva Stock
Innoviva Inc
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally.
Innoviva stock last closed at $20.16, up 0.93% from the previous day, and has increased 8.13% in one year. It has overperformed other stocks in the Biotechnology industry by 0.68 percentage points. Innoviva stock is currently +20.91% from its 52-week low of $16.67, and -8.39% from its 52-week high of $22.00.
At the moment, there are 63.02M INVA shares outstanding. The market value of INVA is $1.27B. In the past 24 hours, 521,000 INVA shares were traded.
How to Buy Innoviva Stock
Not sure how to invest in Innoviva stock? Here's how.
- Figure out where to buy Innoviva stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Innoviva stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Pick your method of payment and add your information.
- Analyze Innoviva stock: The Innoviva ticker symbol is INVA. Is Innoviva stock a good investment? Should you buy shares of INVA? How do INVA's underlying business fundamentals look? Do top analysts think Innoviva is a good buy? Why has INVA's stock price moved recently? (Hint: Our stock research tools can help you figure out if INVA is a good stock to buy).
- Place your INVA trade: Decide if you will purchase INVA shares at the current market price or use a limit order to purchase INVA stock at a specific price.
- Get the latest news on your investment in INVA: Create a watchlist to get the latest news on your investment in Innoviva stock.
Step 1: Figure out where to buy Innoviva stock
You will need a brokerage account in order to access the NASDAQ market and buy INVA stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in INVA today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open a new brokerage account.
- Send your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have opened your account on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help transferring money into your brokerage account.
Step 4: Analyze Innoviva stock
After you have identified the best place to buy Innoviva stock, it's very important to research their stock before you invest, so you can wrap your head around the risk and upside.
Innoviva stock quick numbers
INVA Due Diligence Checks
WallStreetZen was created to help everyday investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on INVA's stock page.
Is INVA stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge INVA's intrinsic value.
Using relative valuations ratios:
- INVA may be undervalued based on its P/E ratio of 33.04x, relative to Biotechnology industry P/E ratio of -111.74x
- INVA may be undervalued based on its P/B ratio of 1.78x, relative to Biotechnology industry P/B ratio of 4.61x
- INVA may be undervalued based on its PEG ratio of 0.55x
You can access more valuation analysis on INVA's stock here.
INVA Financial Health
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the INVA balance sheet.
- There are more short-term assets than long-term liabilities on the INVA balance sheet.
- INVA's operating cash flow of $200.62M allows it to safely service it's debt of $448.92M.
Negative Financial Indicators:
- Total INVA debt is higher than 5 years ago, relative to shareholder equity.
- INVA has a relatively high debt to equity ratio of 0.87.
- INVA profit margin has gone down from 44% to 10.4% in the past year.
- INVA earnings of $85.48M is not enough to cover its interest payments.
Is Innoviva stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 4 sell side analysts who track INVA, the consensus analyst rating on Innoviva is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Innoviva stock forecast page.
INVA Momentum
How are INVA Revenues/Earnings doing?
Last year, INVA earnings were $38.65M. In the past five year, INVA's earnings have grown by -22.98% per year. This was slower than the Biotechnology industry average of 9.05%.
Last year, INVA revenue was $370.23M. Over the past five year, INVA's revenue has gone up by 4.34% per year. This was slower than the Biotechnology industry average of 65.21%.
You can analyze INVA's earnings and revenue performance here.
Are INVA executives and large shareholders buying or selling the stock?
In the past 12 months, executives and large shareholders at INVA have sold more shares than they have bought.
Stephen Basso, Chief Financial Officer of INVA, was the latest INVA insider to sell. They sold $4,728.15 worth of INVA shares on Aug 20, 2025.
Dig into more about who owns INVA stock here.
Does INVA stock generate passive income?
No, Innoviva doesn't provide an income stream by paying out dividends.
What others are saying about INVA
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your INVA trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, use a limit order.
Click the Open button and your broker will place the order.
If you want additional help buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your investment in INVA
Now that you own some INVA stock, you'll want to stay up-to-date on your new company.
Start a watchlist to get alerted to the latest events about your INVA stock.
INVA Feed
How to Buy Stock in Innoviva
To summarize, here are the 6 steps for buying Innoviva stock:
- Figure out where to buy Innoviva stock
- Create a brokerage account
- Put funds into your investment account
- Analyze Innoviva stock
- Place your INVA trade
- Get the latest news on your investment in INVA
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your investment in Innoviva, click the button below.
More Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.